Experimental Procedures
Mice and cell lines NOD-SCID-y chain-/-(NSG) and C57BL/6 (CD45.1 donor and CD45.2 recipient) mice were purchased from Jackson Laboratories, and all animal procedures were performed in animal facility at the University of Pennsylvania in accordance with Federal and Institutional Animal Care and Use Committee requirements. Wild-type parental AsPC1, K562 cells and Nalm6 cells (purchased from American Type Culture Collection) were engineered to express CBG-T2A-GFP as a fluorescent reporter gene and tracer of luciferase activity in vitro and in vivo. K562 with CBG-T2A-GFP cells were further engineered to express human CD19 (K562-CD19) or human mesothelin (K562-Meso). B16F10 (ATCC) was engineered to stably express murine CD19 (GeneCopoeia).
Molecular cloning
The parental vector encoding mesothelin CAR pTRPE SS1BBz contains scFV recognizing human mesothelin, 4-1BB and CD3z intracellular signaling domains. The sequence encoding mature human IL18 (Uniprot Q14116) was synthesized from IDT and cloned into pTRPE SS1BBz along with a T2A (Kim et al., 2011) linker (pTRPE SS1BBz-T2A-hIL18). GFP and humanized CAR CD19BBz were cloned to replace SS1BBz to generate pTRPE CD19BBz-T2A-hIL18 and pTRPE GFP-T2A-hIL18. GFP was cloned to replace SS1BBz to generate pTRPE GFP. GFP was also cloned to replace hIL18 to generate pTRPE SS1BBz-T2A-GFP and pTRPE CD19BBz-T2A-GFP. The parental vector encoding anti-murine CD19 CAR MSGV muCD19BBz contains the 1D3 scFV recognizing murine CD19 (gift from Dr. Taku Kambayashi, UPENN Pathology and Laboratory Medicine) was originally obtained from ATCC (HB-305), murine 4-1BB and CD3z intracellular signaling domains. MSGV muCD19BBz vector was further inserted with a T2A linked GFP or murine IL18 sequence downstream of the CAR.
Primary human T cell expansion Primary donor T cells were transduced with lentivector encoding CAR or GFP with or without hIL18 and expanded as previously reported (Milone et al., 2009) . In brief, primary donor T cells were activated with anti-CD3/CD28 Dynabeads (ThermoFisher) at D0, and transduced with lentivector at D1. Fresh medium was added at D3 and the activated T cells were de-beaded at D5 and maintained at 7e5/ml until rested. T cells were frozen in liquid nitrogen.
Mouse syngeneic T cell expansion Spleens were harvested from CD45.1 donor mice to isolate mouse T cells via anti-CD3 beads (Stemcell Technologies). Purified mouse T cells were activated with Dynabeads mouse CD3x28 beads (ThermoFisher) at a 2:1 ratio of bead:cell. Activated mouse T-cells were transduced with retroviral vector MSGV for CAR expression. Resting murine CART cells following ex vivo expansion were confirmed to have CAR expression and mIL18 secretion, and then washed and injected to CD45.2 recipient mice intravenously.
CRISPR/Cas9 gene knockout Primary donor T cells were transduced with lentivector encoding CAR or GFP with or without hIL18 and engineered with CRISPR/Cas9 system as previously reported (Ren et al., 2016) . In brief, primary donor T cells were activated with anti-CD3/CD28 Dynabeads (ThermoFisher) at D0, and transduced with lentivector at D1. The activated T cells were de-beaded at D3 and electroporated with sgRNA and Cas9 RNA. Then the T cells were maintained at 7e5/ml until rested. T cells were frozen in liquid nitrogen.
TCR-deficient T cells were made with sgRNA targeting GGAGAATGACGAGTGGACCC within the TCRB region. For the IL18R knockout we designed 7 sgRNA targeting IL18RA (Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013) , and utilized RNA electroporation to induce CRISPR/Cas9 mediated gene editing following the procedure of generating TCR KO universal CART (Ren et al., 2016) . The screening of IL18RA KO showed that the A4 sgRNA produced the most efficient gene knockout, and sequencing of the PCR product spanning the gene edited site confirmed mutations in the DNA sequence (GTACAAAAGCAGTGGATCAC) targeted by the A4 sgRNA (data not shown).
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